Back to search
FDAFDA · Food and drugs·Recall number D-0089-2023

Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09

Published December 28, 2022 · Recall initiated: December 7, 2022

Summary

FDA records drug Class II recall D-0089-2023, published December 28, 2022 and initiated December 7, 2022. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 23,736; Lot: Lot #: G102929, Exp 04/2023. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

What to do

Voluntary: Firm initiated · Letter

Get an email if QUINAPRIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
QUINAPRIL
Manufacturer
Lupin Pharmaceuticals Inc.
Distributor
Product was distributed by major distribution chains nationwide.
UPC
0368180559092
Lot
Lot #: G102929, Exp 04/2023
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Quinapril Tablets USP, 20 mg (90 pack), Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, by: Lupin Limited, Goa 403 722 India, NDC# 68180-558-09 recalled?

Yes. FDA published recall D-0089-2023 on December 28, 2022. Reported hazard: CGMP Deviations: Detection of N-Nitroso-quinapril impurity above the acceptable daily intake limit.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: QUINAPRIL. UPC: 0368180559092.